Free Trial

Procter & Gamble (NYSE:PG) Stock Price Up 0.2% - What's Next?

Procter & Gamble logo with Consumer Staples background

The Procter & Gamble Company (NYSE:PG - Get Free Report)'s stock price rose 0.2% during mid-day trading on Tuesday . The company traded as high as $171.95 and last traded at $171.46. Approximately 1,224,938 shares changed hands during trading, a decline of 82% from the average daily volume of 6,660,071 shares. The stock had previously closed at $171.14.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on PG. Morgan Stanley lifted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a report on Monday, October 21st. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a research report on Thursday, September 19th. DZ Bank upgraded Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 target price on the stock in a research report on Thursday, August 29th. Finally, DA Davidson upgraded shares of Procter & Gamble from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average price target of $180.45.

View Our Latest Stock Report on Procter & Gamble

Procter & Gamble Stock Performance

The firm has a market capitalization of $401.13 billion, a PE ratio of 29.37, a P/E/G ratio of 3.70 and a beta of 0.44. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company's fifty day simple moving average is $170.86 and its 200 day simple moving average is $169.75.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the prior year, the business posted $1.83 earnings per share. The business's quarterly revenue was down .6% on a year-over-year basis. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.36%. Procter & Gamble's dividend payout ratio (DPR) is presently 69.31%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the business's stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock valued at $14,629,038 over the last three months. 0.18% of the stock is owned by corporate insiders.

Institutional Trading of Procter & Gamble

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Concurrent Investment Advisors LLC boosted its holdings in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company's stock valued at $16,300,000 after buying an additional 4,035 shares in the last quarter. Copley Financial Group Inc. purchased a new stake in Procter & Gamble in the third quarter worth about $668,000. Synovus Financial Corp lifted its holdings in shares of Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company's stock valued at $32,065,000 after purchasing an additional 6,077 shares during the last quarter. Radnor Capital Management LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth approximately $5,705,000. Finally, Welch Group LLC increased its position in Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company's stock valued at $56,094,000 after buying an additional 2,990 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines